Outpatient continuous parenteral inotropic therapy as bridge to transplantation in children with advanced heart failure

Journal of Cardiac Failure
Jack F PriceSusan W Denfield

Abstract

Advanced heart failure in children is associated with high morbidity and mortality and is often refractory to standard medical therapy. The purpose of this study was to review our institutional experience with the use of outpatient parenteral inotropic therapy (PIT) for advanced chronic heart failure in children. We reviewed the medical records of all patients treated with PIT as outpatients. Seven patients received outpatient PIT from 2/99 to 1/05 (mean age was 14.6 years +/- 3.7). Median duration of therapy was 10 weeks (range 4-84 weeks). The mean number of emergency department visits per patient was greater before starting PIT than after starting PIT (2.3 +/- 1.8 versus 1.1 +/- 2.2, P < .05). The mean number of hospital admissions from exacerbation of heart failure symptoms decreased after starting PIT (2.1 +/- 1.3 versus 0.6 +/- 0.8, P < .05). Mean EF% in patients with systolic dysfunction improved while on therapy (30 +/- 14% before versus 39 +/- 16% after, P < .05). There was 1 death and 5 complications in 2 patients. Six patients were successfully bridged to transplantation. Outpatient continuous parenteral inotropic therapy may serve as a successful bridge to cardiac transplantation in selected pediatric outpatients.

References

Jan 1, 1990·Critical Care Medicine·L W MillerV Herrmann
Jan 15, 1984·The American Journal of Cardiology·J M HodgsonR P Sorkin
Jun 1, 1982·Circulation·C V LeierD V Unverferth
Sep 1, 2000·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·D N RosenthalD Bernstein
Apr 6, 2004·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Shrikanth UpadyaStuart D Katz

❮ Previous
Next ❯

Citations

Oct 23, 2009·Current Treatment Options in Cardiovascular Medicine·Avihu Z Gazit, Phineas P Oren
Dec 14, 2011·British Journal of Anaesthesia·R J IngN A Chambers
Apr 24, 2007·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Alexandria M BergWilliam T Mahle
Sep 21, 2015·International Journal of Cardiology·Simona Silvetti, Markku S Nieminen
Sep 2, 2014·The Journal of Thoracic and Cardiovascular Surgery·Hamood Al KindiDominique Shum-Tim
Sep 18, 2015·Cardiology in the Young·Joseph W Rossano
Jan 22, 2013·Journal of Molecular and Cellular Cardiology·Brian L StaufferCarmen C Sucharov
May 18, 2016·The Journal of Pediatrics·Stephanie J NakanoShelley D Miyamoto
Nov 5, 2016·Journal of Cardiac Failure·Christopher L Holley
Dec 5, 2014·Circulation. Heart Failure·Brian F BirnbaumCharles E Canter
Jul 18, 2019·Journal of the American Heart Association·Toni M WestYang K Xiang
Mar 6, 2016·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Joseph W RossanoTimothy Humlicek
Feb 29, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Anastacia M GarciaStephanie J Nakano
Jan 18, 2012·Current Opinion in Cardiology·Kathleen E Simpson, Charles E Canter
Oct 9, 2015·Journal of Cardiovascular Pharmacology·Katja M GistAlexander A Vinks
May 6, 2017·Heart Failure Reviews·Vijay Urmaliya, Gustavo Franchelli
Oct 22, 2019·Frontiers in Pediatrics·Qing GuoHua Peng
Oct 19, 2019·American Journal of Physiology. Heart and Circulatory Physiology·Stephanie J NakanoBrian L Stauffer
Sep 11, 2020·Current Cardiology Reports·J Blake WallShelley D Miyamoto
Apr 19, 2017·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Max R HolderDaiWai M Olson
Jul 3, 2018·Progress in Pediatric Cardiology·Shelley D MiyamotoKathleen C Woulfe
Jun 18, 2021·Journal of Molecular and Cellular Cardiology·Kathleen C WoulfeCarmen C Sucharov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Susan C BrozenaMariell Jessup
American Heart Journal
Paul J HauptmanMark A Schnitzler
Journal of Molecular and Cellular Cardiology
Carmen SucharovJ David Port
© 2021 Meta ULC. All rights reserved